{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6"],"submitter":["Khalid Y"],"pubmed_abstract":["<h4>Background</h4>Radiation-induced coronary artery disease (R-CAD) has become an increasingly recognized phenomenon. Although the clinical relationship between radiation therapy and CAD risk is well known, there is minimal investigation of the gender relationship to radiation-induced CAD events and the resulting cardiovascular (CV) events/mortality. We study the gender variation in the incidence of CV events/mortality related to R-CAD in Hodgkin's Lymphoma (HL) patients.<h4>Methods</h4>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used in this systematic review and network meta-analysis. OVID, Cochrane Central Register of Controlled Trials via the Wiley Interface, Web of Science Core Collection, MEDLINE, EMBASE, and Google Scholar were in"],"journal":["Cardio-oncology (London, England)"],"pagination":["12"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7405444"],"repository":["biostudies-literature"],"pubmed_title":["Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin's lymphoma: a systematic review."],"pmcid":["PMC7405444"],"pubmed_authors":["Fradley M","Levine A","Shah A","Khalid Y","Dasu N","Dasu K"],"additional_accession":[]},"is_claimable":false,"name":"Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin's lymphoma: a systematic review.","description":"<h4>Background</h4>Radiation-induced coronary artery disease (R-CAD) has become an increasingly recognized phenomenon. Although the clinical relationship between radiation therapy and CAD risk is well known, there is minimal investigation of the gender relationship to radiation-induced CAD events and the resulting cardiovascular (CV) events/mortality. We study the gender variation in the incidence of CV events/mortality related to R-CAD in Hodgkin's Lymphoma (HL) patients.<h4>Methods</h4>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used in this systematic review and network meta-analysis. OVID, Cochrane Central Register of Controlled Trials via the Wiley Interface, Web of Science Core Collection, MEDLINE, EMBASE, and Google Scholar were in","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020","modification":"2025-04-26T13:29:38.482Z","creation":"2025-02-19T01:14:26.072Z"},"accession":"S-EPMC7405444","cross_references":{"pubmed":["32774890"],"doi":["10.1186/s40959-020-00067-7"]}}